Martin & Co Inc
- SEC CIK
- 0001008868
- Latest filing
- Aug 12, 2026
PFE holding history
Pfizer Inc in every 13F filed by Martin & Co Inc, including the quarters it was sold out or no filing was made. Changes compare share counts with the previous calendar quarter.
PFE overviewAll 13F holders of PFEFull Q2 2026 holdings
- Shares (Q2 2026)
- 41,645
- Value
- $1.00M
- % of portfolio
- 0.2%
- Quarters held
- 22
- Since Q1 2021
| Quarter | Shares | Value | % of portfolio | Share change | Action | All holders |
|---|---|---|---|---|---|---|
| Q2 2026 | 41,645 | $1.00M | 0.2% | −46−0.1% | Reduced | Holders |
| Q1 2026 | 41,691 | $1.17M | 0.2% | +356+0.9% | Added | Holders |
| Q4 2025 | 41,335 | $1.03M | 0.2% | +1,635+4.1% | Added | Holders |
| Q3 2025 | 39,700 | $1.01M | 0.2% | +276+0.7% | Added | Holders |
| Q2 2025 | 39,424 | $955.6K | 0.2% | +333+0.9% | Added | Holders |
| Q1 2025 | 39,091 | $990.6K | 0.2% | +851+2.2% | Added | Holders |
| Q4 2024 | 38,240 | $1.01M | 0.3% | −2,645−6.5% | Reduced | Holders |
| Q3 2024 | 40,885 | $1.18M | 0.3% | −120.0% | Reduced | Holders |
| Q2 2024 | 40,897 | $1.14M | 0.3% | −2,082−4.8% | Reduced | Holders |
| Q1 2024 | 42,979 | $1.19M | 0.3% | −1,142−2.6% | Reduced | Holders |
| Q4 2023 | 44,121 | $1.27M | 0.3% | −2,219−4.8% | Reduced | Holders |
| Q3 2023 | 46,340 | $1.54M | 0.4% | +1,229+2.7% | Added | Holders |
| Q2 2023 | 45,111 | $1.65M | 0.4% | −2,136−4.5% | Reduced | Holders |
| Q1 2023 | 47,247 | $1.93M | 0.5% | −797−1.7% | Reduced | Holders |
| Q4 2022 | 48,044 | $2.46M | 0.6% | +1,187+2.5% | Added | Holders |
| Q3 2022 | 46,857 | $2.05M | 0.6% | +1,115+2.4% | Added | Holders |
| Q2 2022 | 45,742 | $2.40M | 0.7% | +404+0.9% | Added | Holders |
| Q1 2022 | 45,338 | $2.35M | 0.6% | −3,290−6.8% | Reduced | Holders |
| Q4 2021 | 48,628 | $2.87M | 0.7% | −228−0.5% | Reduced | Holders |
| Q3 2021 | 48,856 | $2.10M | 0.5% | +3,800+8.4% | Added | Holders |
| Q2 2021 | 45,056 | $1.76M | 0.4% | −1,897−4.0% | Reduced | Holders |
| Q1 2021 | 46,953 | $1.70M | 0.4% | – | – | Holders |
Livermore's 13F data starts with Q1 2021, so Q1 2021 has no change from the previous quarter.